Dr Nazneen Rahman, Founder and CEO of YewMaker and Sustainable Medicines Partnership (SMP) Director describes why digital medicine information is essential for sustainable medicines.
Dr Prebo Barango and Prof Jean-Marie Dangou from the WHO Regional Office for Africa argue that reducing the burden of cardiovascular diseases in Africa is imperative.
Dr Florence Baingana, Regional Advisor, Mental, Neurological, and Substance Use Disorders, World Health Organization (WHO) African Region, provides an update on mental health in the workplace.
Pete Mills, Commercial Technical Operations Manager for Bosch Commercial & Industrial, outlines some of the latest heating technology that could pave the way for net zero in the healthcare sector.
Vasileios Latinos, Coordinator – Urban Resilience and Climate Adaptation, ICLEI Local Governments for Sustainability, European Secretariat, examines the local and regional government perspective of the adaption to climate change.
Dr Erika Kennington, Head of Research and Innovation at Asthma + Lung UK, says that millions of women are drawing the short straw with too little research exploring the effect of female sex hormones on asthma.
Kevin Welstead, Electric Vehicle Sector Director at SSE Energy Solutions, explains why action from local councils is essential to shift vehicles from petrol and diesel to electricity.
Phillip Anderson, Head of Policy at the MS Society UK, describes the need to improve multiple sclerosis treatment, care & support, including access to disease modifying therapies.
Dr Vincent Thornley, Managing Director of Fundamentals Ltd., explores who should pay to power electric vehicles as the market continues to evolve under the EV infrastructure strategy.
Antonia Chitty, Head of Communications and IT at the Association of British Dispensing Opticians, provides insight into sustainable eyewear and eye care procurement.
Despite the rising incidence of Central Nervous System diseases worldwide, efficient treatment options for neurological disorders remain scarce. Treatment failures are principally associated with the inability of drugs to pass the highly selective Blood-Brain Barrier rather than a lack of efficacy.
Dayna Arnold, Project Manager at Zest Consult, a leading digital technology consultancy, discusses the benefits of business-university collaborations to overcome barriers and boost their innovation capabilities.
